CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation

George A. Abou-Rjaily, Jun Lee Sang, Denisa May, Qusai Y. Al-Share, Anthony M. DeAngelis, Randall J. Ruch, Michael Neumaier, Holger Kalthoff, Sue Hwa Lin, Sonia M. Najjar

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Phosphorylation of the cell adhesion protein CEACAM1 increases insulin sensitivity and decreases insulin-dependent mitogenesis in vivo. Here we show that CEACAM1 is a substrate of the EGFR and that upon being phosphorylated, CEACAM1 reduces EGFR-mediated growth of transfected Cos-7 and MCF-7 cells in response to EGF. Using transgenic mice overexpressing a phosphorylation- defective CEACAM1 mutant in liver (L-SACC1), we show that the effect of CEACAM1 on EGF-dependent cell proliferation is mediated by its ability to bind to and sequester Shc, thus uncoupling EGFR signaling from the ras/MAPK pathway. In L-SACC1 mice, we also show that impaired CEACAM1 phosphorylation leads to ligand-independent increase of EGFR-mediated cell proliferation. This appears to be secondary to visceral obesity and the metabolic syndrome, with increased levels of output of free fatty acids and heparin-binding EGF-like growth factor from the adipose tissue of the mice. Thus, L-SACC1 mice provide a model for the mechanistic link between increased cell proliferation in states of impaired metabolism and visceral obesity.

Original languageEnglish (US)
Pages (from-to)944-952
Number of pages9
JournalJournal of Clinical Investigation
Volume114
Issue number7
DOIs
StatePublished - Oct 2004

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'CEACAM1 modulates epidermal growth factor receptor-mediated cell proliferation'. Together they form a unique fingerprint.

Cite this